/
•
•
While earlier attempts were unsuccessful, with Glenmark running into huge losses, there seems to be growing consensus that the drugmaker’s R&D strategy makes it a different company. Perhaps even a valuable one.

April data suggests the slide may be moderating, even as the UAE accelerates moves to derisk its future.
The framework reads less like an agreement between partners and more like a probation order written by the stronger side.
It’s never a good sign when your foreign minister needs a lobbyist to meet US officials. The recent events signal a breakdown in the Modi government’s ability to operate in today’s Washington through its own machinery.